Taurine has been studied in 515 papers since 1975: 144 trials and 35 observational studies in people, 129 in animals, 42 in cells, 159 reviews; 81 in the past year. The newest story, Oct 24, 2026: “Raising taurine improves health during aging in mice”.
Independent labs report that taurine extends worm lifespan; mouse studies and a monkey study report improved healthspan, while fly studies report shorter lifespan or no clear lifespan effect. Human trials report reduced oxidative stress, but a trial in men shows no clear physical-function effect. Some authors have company affiliations, and some papers declare company ties.
820 findings in 326 papers from 1975 to 2026, 16 of them since April 2026
Independent labs found the same change in cells, worms or flies, mice and people. 175 independent labs in 39 countries; 21 trials, 3 about aging, 6 with no results posted.
“taurine supplementation significantly improved markers of metabolic dysfunction (including hemoglobin A1c, fasting blood glucose, fasting insulin, HOMA-IR, total cholesterol, triglycerides, and low-density lipoprotein)”
Cells, worms or flies, mice and humans: replicated by independent labs.
C, W, M, H: cells, worms or flies, mice, humans. Dark: independent labs found the same change there. Light: one lab or one study. Outline: nothing yet.
Labs are independent when their papers share no last author and no institution.
Against: findings that point the other way from most findings on the same outcome.
About aging: the drug’s trials about aging. The total counts its trials for every use.
No results posted: trials that ended over a year ago with no results on ClinicalTrials.gov and no paper reporting them.
Company ties: findings with an author at a company, or from a paper whose competing-interests statement declares ties to one.
175 independent labs in 39 countries
36 findings against
21 trials, 3 about aging, 6 with no results posted
Funders: National Natural Science Foundation of China and others
DrugAge records 9 results from 4 papers: 4 in D. melanogaster, 3 in C. elegans and 2 in mice. Average lifespan is the mean or the median, as each paper reports it.
Taurine decreases oxidative stress and ROS signaling in humans (measured by urinary 8-hydroxy-2-deoxyguanosine, GEE analysis over time) (Beta -0.54; 95% CI -1.08 to -0.01; p = 0.04).
Human trialmeasured by urinary 8-hydroxy-2-deoxyguanosine, GEE analysis over time
Taurine increases plasma taurine concentration in humans (intravenous taurine given to long-term parenteral nutrition patients) (normalized to normal values).
Human trialintravenous taurine given to long-term parenteral nutrition patients10 mg/kg/day
Taurine increases blood lactate in humans during exhaustive exercise under hot and humid conditions (T group peak values higher than P group (P = 0.04)).
Human trialduring exhaustive exercise under hot and humid conditionsn = 12
Taurine showed no clear effect on blood lactate in humans (measured before and after the time trial, with pH and HCO3− showing the same pattern) (no condition main effect (p > 0.05)).
Human trialmeasured before and after the time trial, with pH and HCO3− showing the same patternblood1000 mgmalesn = 11
Taurine decreases systolic blood pressure in humans (compared with control groups in meta-analysis of RCTs) (WMD -3.999 mmHg, 95% CI -7.293 to -0.706).
Reviewcompared with control groups in meta-analysis of RCTsn = 1,024
Taurine is associated with change in HOMA-IR in humans (interaction with diabetes genetic risk score during 2-year weight-loss diet) (P-interaction = .002).
Human trialinteraction with diabetes genetic risk score during 2-year weight-loss diet2 yearsn = 711
Taurine extends worm lifespan across independent labs and improves healthspan in mice and monkeys, but fly studies report unchanged or shorter lifespan. Human trials report no clear effect on physical function in males or mortality after surgery; two registered trials concern aging, while six trials overall ended over a year ago without posted results. Some papers have company-affiliated authors or declared company ties.
Summary rewritten as its findings changed.
As it read before
Independent labs report that taurine extends worm lifespan; a monkey study reports improved healthspan, while a fly study finds no lifespan effect. Human trials report both reduced and unchanged IL-6. Assessed registrations include no aging-focused trials; seven ended over a year ago without posted results or citing papers, and papers disclose Taisho Pharmaceutical affiliations and ties.
Experiments in aged mice found better health span and fewer deaths from sepsis and inflammation after researchers raised taurine levels.Experiments in aged mice found better health span and fewer deaths from sepsis and inflammation after researchers raised taurine levels.
Mouse experiments linked restricted fetal growth to senescence, a state in which cells stop dividing, in the placenta’s blood vessels.Mouse experiments linked restricted fetal growth to senescence, a state in which cells stop dividing, in the placenta’s blood vessels.